Pharmaceutical

Latest Survey from Sotera Digital Reveals Shocking State of Mobile Phone Security in the Workplace.

February 5, 2024, New York - Sotera Digital Security, a leading US based provider of secure communications solutions, has today released its findings from a survey it conducted among over 1,000 senior personnel of large businesses and multinational corporations across the globe. Sectors covered by the survey participants focused on those that require the need for ultra-secure and private communications - both regionally and worldwide - with clients, colleagues and suppliers; namely legal, pharmaceutical, media and corporate affairs, government, and blockchain / AI tech specialists. The survey results provide key

Investors Take Note as Corbus Pharma Releases Data for ADC Tumor Candidate

New York, Jan. 29, 2024 - (Plato Data) - Corbus Pharmaceuticals (NASDAQ:CRBP) jumped on Friday after announcing positive data from a small group of cancer patients who received its antibody-drug conjugate (ADC) CRB-701 in a Phase 1 trial. Citing a December data cut in patients with cancers expressing a tumor-associated antigen called nectin-4, Corbus (CRBP) said that CRB-701 led to an objective response rate (ORR) of 43%, including three partial responses. The data from the first eighteen participants who received the first six dose levels represented the readout, which was

Nutriband’s Innovative Patent Breaks New Ground in Transdermal Medications

Revolutionary AVERSA™ Technology Sets New Standard for Opioid Patch Safety ORLANDO, FL / September 20, 2023 - Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a leading developer of transdermal pharmaceutical products, proudly announces the issuance of a U.S. patent for its cutting-edge AVERSA™ Technology. This groundbreaking innovation, utilizing taste aversion, marks a paradigm shift in addressing the primary routes of abuse associated with opioid-based transdermal patches. The newly granted patent, numbered U.S. patent 11,759,431, titled "Abuse and Misuse Deterrent Transdermal Systems," significantly bolsters Nutriband's intellectual property protection in the United States. It covers

ConV2X Blockchain in Healthcare 2022 Event Announced

Partners in Digital Health has announced the acclaimed ConVerge2Xcelerate (#ConV2X) Blockchain in Healthcare 2022, will be held on site and in person, at the Central Public Library, Thursday, September 15, in Austin, TX, USA. The blockchain event is the premier destination community driving the transformation of healthcare with blockchain and edge technologies. ConV2X presents real world evidence, strategy, operations, research & trends to guide informed decision making to successfully navigate the benefits of this emerging health technology field. The theme for the 2022 program is “Blockchain in Healthcare Today and

Molecule Partners with VitaDAO and Nevermined Creating Pioneering Biopharma IP-to-NFT Transfer

[Press Release – Please see Disclaimer] Molecule, a decentralised biopharma marketplace, has developed a novel IP-to-NFT framework with Web3 technology innovator Nevermined. In a historic transaction, the first biopharma IPNFT was successfully transferred to research collective VitaDAO to fund novel longevity therapeutics at the University of Copenhagen. 18th August 2021, Basel, Switzerland — For the first time in history, NFTs are being used for a transfer of IP ownership in medical research. This unique milestone is a result of a partnership between biopharma IP marketplace Molecule, and VitaDAO, a decentralized

Token Launches From Ethereum to Telegram: Where Do We Go From Here?

In February, United States Securities and Exchange Commission Commissioner Hester Peirce was asked to give her opinion on the SEC’s case against Telegram. She declined to comment at the time, as SEC officials do not speak publicly about ongoing enforcement actions. In late July, however, with the Telegram case settled, Commissioner Peirce gave a speech titled “Not Braking and Breaking” that pointedly questioned the approach taken by the SEC in the Telegram case. Concluding her remarks, Commissioner Peirce asked:“Who did we protect by bringing this action? The initial purchasers, who

VET Geared For New Highs As VeChain Readies Latest Innovations

VeChain has seen a recent four-month rally, which only recently managed to die down. However, depending on the metrics you trust on the matter, a massive breakout event could happen, once more, which could see massive new highs for the currency. VeChain Getting The Best Of Things Of all the various cryptocurrencies the world has to offer thus far, VeChain stands as one that’s had a very good year of 2020. The pandemic may have caused a massive amount of chaos for the crypto industry at large, especially during Black

Introducing the new Blockchain.com monthly newsletter — April Edition: “After the Dust Settles”

The quality of information and data in crypto has improved in recent years, so you may be asking why another monthly newsletter?There are still some big data and analysis gaps in crypto. Crypto markets are nowhere near as widely served with reliable research and data as traditional markets. Indeed, the March 12–13th crypto stress test demonstrated there are also still some very significant issues with the state of crypto exchange infrastructure.What you can expect from our monthly newsletterOur intention with this newsletter is to avoid repeating what you can find

Africa Using Blockchain to Drive Change, Part Two: Southern Solutions

With pundits like Twitter CEO Jack Dorsey predicting that Africa “will define” the future of Bitcoin (BTC), cryptocurrency and blockchain technology continue to attract interest from both public and private establishments across the continent. Many of these adoption cases have been moving beyond finance, developing solutions targeted at issues like unemployment, identity management, health care and supply chain, among others.Amid the growing enthusiasm for crypto and blockchain technology in Africa, industry stakeholders interviewed by Cointelegraph identify a lack of education as one of the major hurdles standing in the way of more